These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 32430101)
21. Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats. Yang JJ; Liu YX; Wang YF; Ge BY; Wang Y; Wang QS; Li S; Zhang JJ; Jin LL; Hong JS; Yin SM; Zhao J Neurosci Bull; 2024 May; 40(5):577-593. PubMed ID: 37973720 [TBL] [Abstract][Full Text] [Related]
22. Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy. Shishmanova-Doseva M; Atanasova D; Uzunova Y; Yoanidu L; Peychev L; Marinov P; Tchekalarova J Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925082 [TBL] [Abstract][Full Text] [Related]
23. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats. Rattka M; Brandt C; Löscher W Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211 [TBL] [Abstract][Full Text] [Related]
24. The Anticonvulsant and Antioxidant Effects of Berberine in Kainate-induced Temporal Lobe Epilepsy in Rats. Mojarad TB; Roghani M Basic Clin Neurosci; 2014; 5(2):124-30. PubMed ID: 25337370 [TBL] [Abstract][Full Text] [Related]
25. Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy. Pitsch J; Kuehn JC; Gnatkovsky V; Müller JA; van Loo KMJ; de Curtis M; Vatter H; Schoch S; Elger CE; Becker AJ Mol Neurobiol; 2019 Mar; 56(3):1825-1840. PubMed ID: 29934763 [TBL] [Abstract][Full Text] [Related]
26. Wogonin preventive impact on hippocampal neurodegeneration, inflammation and cognitive defects in temporal lobe epilepsy. Guo X; Wang J; Wang N; Mishra A; Li H; Liu H; Fan Y; Liu N; Wu Z Saudi J Biol Sci; 2020 Aug; 27(8):2149-2156. PubMed ID: 32742183 [TBL] [Abstract][Full Text] [Related]
27. Anticonvulsant effect of gentamicin on the seizures induced by kainic acid. Zhao Y; Wang Z; Lao W; Kuang P; Jiang N; Yin T; Lin W; Zhu H; Ji Y Neurol Res; 2018 Jan; 40(1):45-52. PubMed ID: 29088985 [TBL] [Abstract][Full Text] [Related]
28. Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis. Haghani S; Jamali-Raeufy N; Zeinivand M; Mehrabi S; Aryan L; Fahanik-Babaei J Basic Clin Neurosci; 2021; 12(6):805-816. PubMed ID: 35693152 [TBL] [Abstract][Full Text] [Related]
29. Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy. Seegers U; Potschka H; Löscher W Epilepsy Res; 2002 Oct; 51(3):257-68. PubMed ID: 12399076 [TBL] [Abstract][Full Text] [Related]
31. Sinomenine exerts anticonvulsant profile and neuroprotective activity in pentylenetetrazole kindled rats: involvement of inhibition of NLRP1 inflammasome. Gao B; Wu Y; Yang YJ; Li WZ; Dong K; Zhou J; Yin YY; Huang DK; Wu WN J Neuroinflammation; 2018 May; 15(1):152. PubMed ID: 29776417 [TBL] [Abstract][Full Text] [Related]
32. Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model. Godoy LD; Liberato JL; Celani MVB; Gobbo-Neto L; Lopes NP; Dos Santos WF Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28841161 [TBL] [Abstract][Full Text] [Related]
33. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy. Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748 [TBL] [Abstract][Full Text] [Related]
34. The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy. Vazifehkhah S; Khanizadeh AM; Mojarad TB; Nikbakht F J Chem Neuroanat; 2020 Nov; 109():101849. PubMed ID: 32679167 [TBL] [Abstract][Full Text] [Related]
35. Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Bankstahl M; Klein S; Römermann K; Löscher W Neuropharmacology; 2016 Oct; 109():183-195. PubMed ID: 27288003 [TBL] [Abstract][Full Text] [Related]
36. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Klein S; Bankstahl M; Löscher W Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186 [TBL] [Abstract][Full Text] [Related]
37. Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Twele F; Töllner K; Brandt C; Löscher W Epilepsy Behav; 2016 Feb; 55():47-56. PubMed ID: 26736063 [TBL] [Abstract][Full Text] [Related]
38. The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy. Pottoo FH; Tabassum N; Javed MN; Nigar S; Rasheed R; Khan A; Barkat MA; Alam MS; Maqbool A; Ansari MA; Barreto GE; Ashraf GM Mol Neurobiol; 2019 Feb; 56(2):1233-1247. PubMed ID: 29881945 [TBL] [Abstract][Full Text] [Related]
39. Baicalein improves cognitive deficits and hippocampus impairments in temporal lobe epilepsy rats. Qian X; Wang ZR; Zheng JJ; Ding JQ; Zhong JG; Zhang TY; Li W; Zhang M Brain Res; 2019 Jul; 1714():111-118. PubMed ID: 30817901 [TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy. Pearson JN; Rowley S; Liang LP; White AM; Day BJ; Patel M Neurobiol Dis; 2015 Oct; 82():289-297. PubMed ID: 26184893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]